Ascendis Pharma A (ASND) Construction in Progress (2019 - 2021)
Ascendis Pharma A (ASND) posted Construction in Progress of $2173.5 for Q4 2021, down 20.74% sequentially from $2742.3 in Q4 2020, and down 20.74% YoY from $2742.3 in Q4 2020.
Ascendis Pharma A (ASND) Construction in Progress (2019 - 2021) Analysis & Trends
Ascendis Pharma A has reported Construction in Progress for 3 years, with the latest figure at $2173.5 in Q4 2021.
- Quarterly Construction in Progress fell 20.74% year-over-year to $2173.5 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2173.5 (down 20.74% YoY) and the FY2021 annual result came in at $2173.5, down 20.74% from the prior year.
- Construction in Progress retreated to $2173.5 in Q4 2021 per ASND's latest filing, from $2742.3 in the prior quarter.
- Over five years, Construction in Progress peaked at $3.0 million in Q4 2019 and troughed at $2173.5 in Q4 2021.
- A 3-year average of $997837.5 and a median of $2742.3 in 2020 frame the typical range for Construction in Progress.
- The sharpest annual moves came in 2020 and 2021: Construction in Progress plunged 99.91% in 2020, then retreated 20.74% in 2021.
- Over 3 years, Construction in Progress stood at $3.0 million in 2019, then slumped by 99.91% to $2742.3 in 2020, then dropped by 20.74% to $2173.5 in 2021.
- According to Business Quant data, Construction in Progress over the past three periods registered $2173.5, $2742.3, and $3.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 152.67 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2,173.54 |
| Dec 31, 2020 | 2,742.27 |
| Dec 31, 2019 | 2.99 Mn |